CASP1 and hepatocellular carcinoma: Also, Wei et al. showed that E2-induced activation of the NLRP3 inflammasome promoted caspase-1-dependent pyroptotic cell death in HCC cells which may be a potential neoplastic target for the treatment of HCC [13].